Cholesterol 24-Hydroxylase-IN-1(Cat No.:I044053)is a selective inhibitor of cholesterol 24-hydroxylase (CYP46A1), an enzyme that converts cholesterol into 24S-hydroxycholesterol, a key step in cholesterol turnover in the brain. By blocking CYP46A1 activity, this compound reduces 24S-hydroxycholesterol production, affecting cholesterol homeostasis and neuronal signaling. It is especially valuable in neuroscience research, including studies on Alzheimer’s disease, epilepsy, and neurodegeneration. Cholesterol 24-Hydroxylase-IN-1 supports investigation into the therapeutic potential of modulating brain cholesterol metabolism and offers a targeted approach to exploring the role of CYP46A1 in cognitive and neuroinflammatory disorders.